Immunotherapy is advancing cancer treatment. One treatment in particular, chimeric antigen receptor T-cell (CAR T) therapy, is improving lives for patients with lymphoma. In this webinar, Winship hematologist Jean Koff, MD, MS, discussed updates in the use of CAR T-cell therapy as a promising treatment strategy for patients with certain types of lymphoma.
Presenter:
Jean Koff, MD, MS
Assistant Professor, Hematology and Medical Oncology
Emory University School of Medicine
Webinar is intended for healthcare professionals, and is hosted by Winship Cancer Institute of Emory University (https:/winshipcancer.emory.edu). For more webinars, visit: https:winshipcancer.emory.edu/webinars.
